Kenalog in Orabase: Uses, Dosage, Alternatives & Discontinuation

Anyone who’s had a mouth ulcer knows the sharp sting every time you eat something salty or acidic. Kenalog in Orabase, a prescription dental paste containing 0.1% triamcinolone acetonide, has long been a reliable treatment for these painful sores. But with supply disruptions and regional shortages making it harder to find, many patients are asking what happened — and what actually works instead.

Active Ingredient: Triamcinolone acetonide 0.1% · Form: Dental paste (Orabase) · Prescription Required: Yes (Rx-only in most countries) · Typical Course Length: Up to 7 days · Manufacturer: Various; originally Bristol-Myers Squibb · Available Generic: Triamcinolone dental paste (multiple sources)

Six key facts about Kenalog in Orabase, pulled directly from prescribing information and regulatory sources:

What is Kenalog in Orabase used for?

Kenalog in Orabase is a prescription dental paste that combines triamcinolone acetonide — a mid-potency corticosteroid — with an adhesive base called Orabase. The paste sticks to the moist lining of the mouth and delivers the steroid directly to inflamed tissue. According to the Australian Commission on Safety and Quality in Health Care, it is indicated for tenderness, pain, inflammation, and ulceration inside the mouth or on the gums, including lesions caused by dentures or oral lichen planus.

How does Kenalog in Orabase work?

• Triamcinolone acetonide suppresses the local immune response and reduces inflammation at the ulcer site (PharmaServe mechanism description)
• The Orabase vehicle creates a physical barrier that protects the sore from food, saliva, and mechanical irritation (Kenalog Australia product site)
• The paste forms a slippery film that stays in place for several hours (Kenalog Australia)

The implication: it treats the inflammation itself rather than just numbing the pain. This is what separates it from simple protective gels or local anaesthetics.

Step-by-step application guide

1. Gently dry the ulcer with a clean tissue to help the paste adhere.
2. Squeeze a pea-sized amount (6-10mm) onto a clean fingertip.
3. Dab the paste onto the ulcer; do not rub it in.
4. Avoid eating or drinking for at least 30 minutes to allow the film to form.

What conditions does Kenalog in Orabase treat?

• Aphthous ulcers (canker sores) — the most common indication (WebMD indication list)
• Traumatic ulcers from braces, dentures, or accidental bites (Australian Commission on Safety and Quality in Health Care)
• Oral lichen planus lesions and other inflammatory oral conditions (Kenalog Australia)

How effective is Kenalog in Orabase for mouth ulcers?

• Clinical data shows it accelerates healing of aphthous ulcers compared to placebo or protective pastes alone (PharmaServe drug monograph)
• The Kenalog Australia product site reports it provides triple action: heals ulcers rapidly, relieves pain, and protects via barrier
• Some evidence suggests it may help suppress recurrence of mouth ulcers, though this is less well-established in controlled trials

The implication: patients with moderate-to-severe ulcers have a clear medical benefit from using this paste, while mild cases can rely on simpler treatments.

Can you buy Kenalog in Orabase over the counter?

The short answer: no, not in most countries. Kenalog in Orabase is classified as a prescription-only medication in virtually every regulated market. The Australian Commission on Safety and Quality in Health Care lists it as Schedule 4 (prescription only) in Australia. In the United Kingdom it is a Prescription-Only Medicine (POM). The United States also requires a prescription for triamcinolone dental paste.

Is Kenalog in Orabase prescription-only?

Yes. The triamcinolone component is a corticosteroid that requires medical oversight. According to the WebMD drug summary, it should not be used if there is an infection present in the mouth or throat, which is one reason a professional evaluation is needed before prescribing. The Kenalog Australia product site also advises against use during pregnancy unless specifically recommended by a doctor, reinforcing the need for a medical consultation.

Where is Kenalog in Orabase available without prescription?

• Some jurisdictions allow the Orabase base alone (without the steroid) to be sold over the counter as a protective paste (PharmaServe product notes)
• In certain countries with less stringent regulations, a pharmacist may supply it without a prescription, but this is increasingly rare
• Online pharmacies that advertise “no prescription needed” should be treated with caution — they are likely operating outside regulatory frameworks

What are the legal requirements to obtain Kenalog in Orabase?

• A valid prescription from a dentist, doctor, or oral medicine specialist (WebMD prescribing information)
• In Australia, it is Schedule 4, meaning it must be prescribed and dispensed by a registered pharmacist (Australian Commission on Safety and Quality in Health Care)
• Repeat prescriptions may be issued, but the maximum course is typically 7 consecutive days without re-evaluation

The pattern across markets is clear: prescription requirements are non-negotiable, and patients should avoid questionable sources.

The pattern across all regulated markets is consistent: a prescription is required. Anyone claiming otherwise is likely selling an unapproved or counterfeit product.

Is Kenalog the same as Bonjela?

No — and the difference matters for treatment decisions. Kenalog in Orabase and Bonjela are both used for mouth ulcers, but they work through completely different mechanisms and are not interchangeable. One is a prescription corticosteroid, the other is an over-the-counter analgesic and antiseptic.

Three key differences, one pattern: potency, mechanism, and regulatory status diverge sharply between the two products.

What are the active ingredients in Kenalog and Bonjela?

• Kenalog: triamcinolone acetonide, a corticosteroid that reduces inflammation by blocking phospholipase A2 and inflammatory cytokine production (WebMD pharmacology notes)
• Bonjela: choline salicylate, a salt of salicylic acid that inhibits cyclooxygenase (COX) enzymes to reduce pain and inflammation, plus cetalkonium chloride as an antiseptic (PharmaServe comparison notes)

How do Kenalog and Bonjela differ in use?

• Kenalog is dabbed on and left to form a film; it stays in place for hours (Kenalog Australia application guide)
• Bonjela is applied more frequently (every 3 hours) and can be rubbed in gently (WebMD comparison notes)
• Kenalog treats inflammation at the source; Bonjela primarily manages pain symptoms

Which is more effective for mouth ulcers?

“Effective” depends on severity. For large, painful, or recurrent aphthous ulcers, Kenalog in Orabase is clinically more potent because it addresses the underlying inflammatory process. For occasional mild sores, Bonjela works fine as a pain management tool. The Australian Commission on Safety and Quality in Health Care notes that Kenalog is specifically indicated for inflammatory lesions, whereas Bonjela is a general analgesic.

What this means: the choice between these two products depends entirely on ulcer severity and the need for anti-inflammatory action.

Why has Kenalog been discontinued?

This is the question generating the most online searches — and the answer is more nuanced than a simple yes or no. Kenalog in Orabase has not been universally discontinued, but it has faced significant supply disruptions that make it feel discontinued to many patients.

Has Kenalog in Orabase been discontinued globally?

• No. The dental paste remains approved and marketed in several countries, including Australia, where the Kenalog Australia product site still lists it as an active product
• The injectable form of Kenalog (triamcinolone acetonide injection) has faced more severe discontinuation in markets like the UK and Australia due to manufacturing changes and raw material shortages
• Supply of the dental paste has been inconsistent, with the Australian TGA listing it on shortage registers as recently as 2023-2024

What led to the discontinuation of Kenalog?

• Manufacturing changes at the source production facilities disrupted global supply of triamcinolone acetonide raw material (TGA shortage notification archive)
• Bristol-Myers Squibb, the original manufacturer, shifted production priorities, leading to gaps in supply for certain formulations
• Regulatory pressures and consolidation in the generic pharmaceutical market reduced the number of manufacturers producing triamcinolone dental paste

Are there still supplies of Kenalog in Orabase available?

• Supplies exist but are sporadic — some pharmacies report stock, others cannot obtain it for weeks or months (WebMD availability notes)
• Generic versions (triamcinolone dental paste) are available from multiple manufacturers, but they face the same raw material constraints
• Patients in Australia and the UK have reported difficulty filling prescriptions in 2023-2024 based on community pharmacy forums and patient reports

The catch: the dental paste is not gone, but it is unreliable; patients must plan ahead and explore alternatives.

What are the disadvantages of Kenalog?

No medication is without downsides, and Kenalog in Orabase has several that patients should understand before using it — especially if they plan to use it regularly.

What are the side effects of Kenalog in Orabase?

• Burning or stinging immediately after application — usually transient (WebMD side effect profile)
• Dryness or irritation at the application site (WebMD)
• With prolonged or excessive use: oral candidiasis (thrush), delayed wound healing, local immunosuppression (Australian Commission on Safety and Quality in Health Care)

Is Kenalog a strong steroid?

Triamcinolone acetonide is classified as a mid-potency corticosteroid — stronger than hydrocortisone but less potent than clobetasol or betamethasone. For topical oral use, 0.1% triamcinolone is considered appropriate for inflammatory lesions but should not be used long-term. The Australian Commission on Safety and Quality in Health Care advises against courses longer than 7 days without medical re-evaluation.

Are there safer alternatives to Kenalog?

• Bonjela (OTC, milder, for pain relief only) — appropriate for mild, occasional ulcers
• Adcortyl in Orabase (same mechanism, similar potency, also facing supply issues)
• Orabase plain (protective paste without steroid) — available OTC in some countries
• Cod Liver Oil – Benefits, Dosage and Safety Guide — not directly comparable but some patients explore nutritional approaches to reducing inflammation
• Simple home remedies: salt water rinses, honey, chamomile tea compresses

The takeaway: Kenalog is effective but requires careful, short-term use under medical guidance.

Timeline of supply disruptions

Four periods, one pattern: manufacturing fragility has made a reliable product unreliable for patients who depend on it.

• 2020 — Initial global supply shortage reports for Kenalog injectable due to manufacturing issues at source facilities (TGA shortage notification archive)
• 2022 — Discontinuation of Kenalog injectable in some markets (e.g., UK, Australia); dental paste supply begins to tighten
• 2023 — Kenalog in Orabase added to Australian TGA shortage list; limited availability confirmed
• 2024 — Continued sporadic supply; patients in Australia and the UK report difficulty obtaining the dental paste from community pharmacies

The signal: supply reliability remains low, and patients should not count on immediate availability.

Confirmed facts vs. what’s unclear

The balance: most clinical facts are well-supported, but availability and long-term data remain uncertain.

What experts and regulators say

Kenalog in Orabase is indicated for the adjunctive treatment and temporary relief of symptoms associated with oral inflammatory lesions and ulcerative conditions.

— Drug monograph, Australian Commission on Safety and Quality in Health Care (regulatory authority)

Triamcinolone dental paste works by reducing inflammation and discomfort from mouth sores or ulcers. It should not be used longer than 7 days unless directed by your doctor.

— Prescribing summary, WebMD drug encyclopedia (clinical reference)

Apply by dabbing a 6mm amount to the ulcer after meals and at bedtime. Do not rub it in. The paste forms a slippery film that stays in place and continues to work.

— Patient instructions, Kenalog Australia product site (manufacturer guidance)

Summary

Kenalog in Orabase remains a clinically effective treatment for moderate-to-severe mouth ulcers, but its reliability as a treatment option has eroded due to supply chain fragility. Patients who need it should work with their dentist or doctor to secure a prescription and check local pharmacy stock before assuming availability. For the Australian patient facing another painful ulcer and an empty pharmacy shelf, the choice is clear: ask about generic triamcinolone dental paste, or have a conversation about OTC alternatives like Bonjela — because waiting for the supply to return is not a treatment plan.

Frequently asked questions